Advertisement
AnPac Bio-Medical Science... (ANPC)
NASDAQ: ANPC
· Real-Time Price · USD
4.30
-0.14 (-3.15%)
At close: May 19, 2023, 7:59 PM
-3.15% (1D)
| Bid | n/a |
| Market Cap | 26.97M |
| Revenue (ttm) | 12.04M |
| Net Income (ttm) | -101.32M |
| EPS (ttm) | -11.45 |
| PE Ratio (ttm) | -0.37554585152838427 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 35,704 |
| Avg. Volume (20D) | 22,069 |
| Open | 4.57 |
| Previous Close | 4.44 |
| Day's Range | 4.25 - 4.63 |
| 52-Week Range | 2.60 - 11.99 |
| Beta | 1.56 |
About ANPC
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China....
Industry Biotechnology
Sector Healthcare
IPO Date Jan 30, 2020
Employees 89
Stock Exchange NASDAQ
Ticker Symbol ANPC
Website https://www.anpacbio.com